Tag: Biopharma

The Perils of Product Liability Insurance When Mass Litigation Strikes

Based on a report yesterday from the Cook County Register, a settlement has apparently been reached between Abbvie and plaintiffs in the testosterone replacement therapy drug cases.  Currently there are 25,000 cases pending and this settlement could bring to a close the latest chapter in life science mass product litigation.  What has most likely prompted … Continue reading The Perils of Product Liability Insurance When Mass Litigation Strikes →

Possible Opioid Settlement and the Role of Product Liability Insurance

The recent headline, “Opioid Lawsuits Look More Like A Tobacco Settlement Every Day” in Forbes grabbed my attention for reasons I will explain.  As you know, I help life science companies develop and implement insurance programs that enables them to transfer risk to the insurance company.  So when you see a headline that reads like … Continue reading Possible Opioid Settlement and the Role of Product Liability Insurance →

How Changing the Reporting Period for Public Companies to Semiannual Could Impact the D&O Market

Last week the issue of public companies having to do quarterly reports popped up in the news in a big way with the President tweeting and then speaking on the possibility of ending quarterly reporting.  There are a lot of opinions out there on whether this is a good idea or bad idea.  Some people … Continue reading How Changing the Reporting Period for Public Companies to Semiannual Could Impact the D&O Market →